Organogenesis (ORGO) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for Organogenesis
Is Organogenesis a buy right now? The alternative data says hold. This ORGO stock analysis is built on the 25+ alternative data signals AltIndex tracks on Organogenesis every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 45/100: a Hold. The stock trades at $1.29 with a $166M market cap.
The soft spots over the past 90 days: revenue down 60.0% YoY to $40M. The rest of the signal set is holding steady, which keeps ORGO at a hold rather than a sell.
ORGO’s broader alt-data profile also covers job postings (14 open roles), headcount (826 employees, according to LinkedIn), web traffic (7K monthly visits), and business outlook (8% of employees positive). Every signal links to its own page with full history, the ORGO technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on ORGO is just below.
Organogenesis AI Stock Analysis
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of advanced wound care, orthopedics, and surgical biologics products. The company leverages its extensive portfolio of marketed products to deliver transformative and innovative solutions for patients with complex circumstances.
Analysis generated September 30, 2026.
Recent Organogenesis Stock Alerts
|
Organogenesis | September 28 Business Outlook among employees is down by 11.1% over the last month. |
|
Organogenesis | September 22 Price is up by 6.4% in the last 24h. |
|
Organogenesis | September 8 Price is down by -6.4% in the last 24h. |
|
Organogenesis | August 24 Price is down by -6.1% in the last 24h. |
Organogenesis Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 7K | N/A | |
| Job Posts | 14 | N/A | |
| LinkedIn Employees | 826 | N/A | |
| Employee Recommend | 23 | N/A | |
| Business Outlook | 8 | N/A | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 38 | N/A | |
| Stocktwits Mentions | 0 | 100.0% | |
| News Mentions | 2 | N/A | |
| Stocktwits Subscribers | 3K | N/A | |
| Instagram Followers | 351 | N/A | |
| Facebook Followers | 3K | N/A | |
| Facebook Engagement | 7 | N/A |
About Organogenesis (ORGO)
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports medicine markets in the United States. The company is headquartered in Canton, Massachusetts.
| Price | $1.29 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $166M |
| Year Range | $1 – $7 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Drug Manufacturers |
Latest Organogenesis News
View more →
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg UlcersJuly 27 - GlobeNewswire |
|
FuChi is a cell cycle biosensor for tracking cell cycle dynamics during avian developmentOctober 9 - Plos.org |
|
New insights into Müllerian duct differentiation provided by single cell transcriptomics in the chicken embryoOctober 9 - Plos.org |
|
The histone methyltransferase complex subunit RBBP5 serves as a central epigenetic regulator of proteostasis dynamicsOctober 8 - Plos.org |
|
Type III effectors of symbiotic Rhizobia include diverse predicted transcriptional and post-transcriptional modulatorsOctober 8 - Plos.org |
See Organogenesis’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for ORGO, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEOrganogenesis Earnings & Financial Performance
View all earnings →Organogenesis Insider Trading Activity
View all →| Leibowitz Arthur S filed to sell 291,014 shares at $0.0. Mar 9 '26 |
| Driscoll Michael Joseph filed to sell 225,707 shares at $0.0. Mar 9 '26 |
| NUSSDORF GLENN H filed to sell 2,565,591 shares at $0.0. Dec 16 '25 |
| NUSSDORF GLENN H filed to sell 2,765,591 shares at $0.0. Nov 26 '25 |
| NUSSDORF GLENN H filed to sell 2,953,548 shares at $0.0. Nov 25 '25 |
Organogenesis Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Organogenesis
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Journey MedicalDERM |
$6.31 6.1% | $168M | 49 |
 |
Cardiol TherapeuticsCRDL |
$1.23 5.4% | $158M | 50 |
 |
vTv TherapeuticsVTVT |
$31.18 3.7% | $119M | 56 |
 |
SIGA TechnologiesSIGA |
$3.28 0.0% | $236M | 62 |
 |
Lifecore BiomedicalLFCR |
$6.45 0.3% | $244M | 41 |
Explore Organogenesis Data
Frequently Asked Questions: Organogenesis (ORGO)
Organogenesis has an AltIndex AI Score of 45/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
45/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Organogenesis (ORGO) stock is $1.29 with a market cap of $166M.
As of today, Organogenesis’s PE (Price to Earnings) ratio is —.
View the latest Organogenesis insider transactions to see recent buying and selling activity by company executives and directors.
Check the Organogenesis congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The ORGO stock price chart above shows Organogenesis’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Organogenesis technical analysis for RSI, moving averages, and more.
See the stocks similar to Organogenesis section on this page for companies in the same industry ranked by market cap and AI Score.
